title: Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF.
authors: G W
authors: GW
authors: Basak
authors: W
authors: W
authors: Wiktor-Jedrzejczak
authors: J F
authors: JF
authors: Apperley
authors: K W
authors: KW
authors: Douglas
authors: I H
authors: IH
authors: Gabriel
authors: C
authors: C
authors: Geraldes
authors: K
authors: K
authors: Hübel
authors: O
authors: O
authors: Jaksic
authors: Z
authors: Z
authors: Koristek
authors: F
authors: F
authors: Lanza
authors: R
authors: R
authors: Lemoli
authors: G
authors: G
authors: Mikala
authors: D
authors: D
authors: Selleslag
authors: N
authors: N
authors: Worel
authors: M
authors: M
authors: Mohty
authors: R F
authors: RF
authors: Duarte
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001596:Benzylamines; D015992:Body Mass Index; D000075202:Contraindications; D000080027:Cyclams; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006571:Heterocyclic Compounds / Q000008:administration & dosage*; D006689:Hodgkin Disease / Q000473:pathology; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000473:pathology; D009765:Obesity / Q000503:physiopathology; D050177:Overweight / Q000503:physiopathology; D012189:Retrospective Studies; D013851:Thinness / Q000503:physiopathology; D055815:Young Adult
chemical_list: D001596:Benzylamines; D000080027:Cyclams; D006571:Heterocyclic Compounds; D016179:Granulocyte Colony-Stimulating Factor; C088327:plerixafor